A carregar...
Advances in treatment for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation
The majority of newly diagnosed multiple myeloma patients are over 65 years and/or physically unfit, and, therefore, are not eligible for standard treatment with high-dose chemotherapy and stem cell transplantation. The treatment goals in these patients should be to ensure improvement in disease man...
Na minha lista:
| Publicado no: | Leukemia Suppl |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4851189/ https://ncbi.nlm.nih.gov/pubmed/27175257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leusup.2013.5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|